| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | WO2007025351A1 Tissue disruption treatment and composition for use thereof |
| 03/08/2007 | WO2006135915A3 Methods and compositions for treating degenerative bone disorders |
| 03/08/2007 | WO2006128184A3 Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006054319A3 Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins |
| 03/08/2007 | WO2006042329A3 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 03/08/2007 | WO2006027579A3 The treatment of inflammatory disorders and pain |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | US20070054962 Method for treating acute or chronic pain |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 03/08/2007 | US20070054878 Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis |
| 03/08/2007 | US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | DE202006019784U1 Tee-Mischung Tea Mix |
| 03/08/2007 | DE202006016697U1 Assay für Lanthanhydroxycarbonat Assay for Lanthanhydroxycarbonat |
| 03/08/2007 | DE102005042139A1 Verwendung von Enzianwurzel-Maische und entsprechende Mittel Use of gentian root mash and corresponding means |
| 03/08/2007 | CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | CA2624316A1 Tissue disruption treatment and composition for use thereof |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620127A1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 03/07/2007 | EP1760144A2 Cartilage and bone repair composition |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1760079A1 Compounds as cor5 antagonists |
| 03/07/2007 | EP1759710A1 Remedy or preventive for arthritis |
| 03/07/2007 | EP1759708A1 IFN-beta for treating bone disorder related to cancer |
| 03/07/2007 | EP1759001A1 Bone delivery conjugates and method of using same to target proteins to bone |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758870A1 4-phenyl-pyrimidine-2-carbonitrile derivatives |
| 03/07/2007 | EP1758866A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines |
| 03/07/2007 | EP1758651A2 Lxr agonists to promote bone homeostasis |
| 03/07/2007 | EP1758613A2 Compositions and methods for modulating bone mass |
| 03/07/2007 | EP1758607A1 Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility |
| 03/07/2007 | EP1758594A1 Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol) |
| 03/07/2007 | EP1758572A1 Combinations of hyaluronic acid and polyunsaturated fatty acids |
| 03/07/2007 | EP1758562A2 Compositions and methods for bone formation and remodeling |
| 03/07/2007 | EP1534305B9 Treating cartilage / bone conditions with water-soluble strontium salts |
| 03/07/2007 | EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/07/2007 | EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1406591B1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 03/07/2007 | EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1187811B1 Inhibitors of metalloproteinases |
| 03/07/2007 | EP1043998B1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS |
| 03/07/2007 | EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1923813A Aporphine and use of oxidized aporphine alkaloid |
| 03/07/2007 | CN1923798A Preparation method of dexibuprofen amino acid salt and application |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923790A Kutkin derivative, preparation method and application thereof |
| 03/07/2007 | CN1923265A Application of wheat germ oil in pharmaceutical preparation for preventing and treating osteoporosis |
| 03/07/2007 | CN1923263A Traditional Chinese medicine composition, its preparing method and quality controlling means |
| 03/07/2007 | CN1923252A Oral medication for curing bone injury |
| 03/07/2007 | CN1923234A Traditional Chinese medicinal formulation for treating osteoarthropathy |
| 03/07/2007 | CN1923230A Medicine for treating rheumatism and rheumatoid disease, and its preparation method |
| 03/07/2007 | CN1923210A Diructose anhydride-containing composition and use thereof |
| 03/07/2007 | CN1923194A Preparation method and application of cortex fraxini extract |
| 03/07/2007 | CN1923168A External use plaster for treating acute jerk contused wound |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1302791C Oral medication for bones injuries of brain |
| 03/07/2007 | CN1302787C Use of several plant oils in medicinal formulation for preventing and treating osteoporosis and skin senility |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186840 Quinoline derivatives as anti-inflammatory agents |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186820 Antibody for use in the treatment of rheumatic and osteoarthritis |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186809 Methods and compositions relating to anti-interleukin-4 receptor antibodies |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186708 Steroidal compounds |
| 03/06/2007 | US7186695 Administering organic arsenic compounds such as 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide for prophylaxis of degenarative joint disease; antiarthritic agents |
| 03/06/2007 | US7186418 Composition and use of RAR antagonists for promoting chondrogenesis |
| 03/06/2007 | US7186411 Vaccines absorbable by the transmucosal way |
| 03/01/2007 | WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023875A1 Technique for culture of mesenchymal stem cell utilizing laminin-5 |
| 03/01/2007 | WO2007023776A1 Prophylactic or therapeutic agent for osteoporosis having pharmacological efficacy confirmed in simian model |
| 03/01/2007 | WO2007022999A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | WO2006138347A3 Androgen receptor modulator compounds and methods |
| 03/01/2007 | WO2006119965A3 Growth factor mutants with altered biological attributes |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049639 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |